We are live on ! Find out more
ASBPW

Aspire Biopharma Warrant
ASBPW

39 hedge funds and large institutions have $726K invested in Aspire Biopharma Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 40 → 39 (-1)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

37% less capital invested

Capital invested by funds: $1.15M → $726K (-$426K)

Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
3
Calls
$2.36M
Puts
–
Net Calls
+$2.36M
Net Calls Change
+$234K

Top Buyers

Rank Fund Capital Flow
1
FSI
Flow State Investments
Illinois
+$2.92K
2
MC
Meteora Capital
Florida
+$2.02K
3
Walleye Capital
Walleye Capital
New York
+$1.18K
4
Walleye Trading
Walleye Trading
New York
+$661
5
UBS Group
UBS Group
Switzerland
+$37

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$652K
2
KC
Kepos Capital
New York
-$18K
3
LCM
Landscape Capital Management
New Jersey
-$751
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$612
5
AC
Athos Capital
Hong Kong
-$292
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
26
Picton Mahoney Asset Management
Ontario, Canada
$3K – – –
CS
27
Clear Street
New York
$2.76K – -2 -0%
ACM
28
Atalaya Capital Management
New York
$2.5K – – –
Walleye Capital
29
Walleye Capital
New York
$2.36K +$1.18K +14,560 +46%
Walleye Trading
30
Walleye Trading
New York
$1.33K +$661 +8,190 +46%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$1.32K -$612 -7,583 -22%
EFI
32
EHP Funds Inc
Canada
$1.27K – – –
MC
33
Meteora Capital
Florida
$1.27K +$2.02K +25,000 New
OAC
34
OMERS Administration Corp
Ontario, Canada
$1.25K – – –
MTCM
35
Mint Tower Capital Management
Netherlands
$1K – – –
BI
36
Bulldog Investors
New Jersey
$634 – – –
PI
37
PEAK6 Investments
Illinois
$634 – – –
UBS Group
38
UBS Group
Switzerland
$23 +$37 +453 New
IRC
39
Investors Research Corp
Georgia
$1 – – –
KC
40
Kepos Capital
New York
– -$18K -350,000 Closed
MP
41
Mangrove Partners
Connecticut
– -$652K -62,605 Closed
LCM
42
Landscape Capital Management
New Jersey
– -$751 -14,999 Closed
1
2

ASBPW Hedge Fund Activity: Q3 2023 in Review

39 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma Warrant (ASBPW) for Q3 2023, worth a combined $726K — down 37% from $1.15M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ASBPW and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.

The largest buyer was Flow State Investments, adding an estimated $2.92K. The largest seller was Mangrove Partners, exiting entirely with an estimated $652K sold.

  • 39 institutional investors held Aspire Biopharma Warrant (ASBPW) as of Q3 2023, down from 40 in Q2 2023.
  • Funds reported $726K of Aspire Biopharma Warrant stock for Q3 2023, down 37% quarter-over-quarter.
  • 2 funds opened new Aspire Biopharma Warrant positions in Q3 2023 and 3 closed out, a net change of -1 holder.
  • The largest Aspire Biopharma Warrant buyer in Q3 2023 was Flow State Investments, an estimated $2.92K added.
  • The largest Aspire Biopharma Warrant seller in Q3 2023 was Mangrove Partners, an estimated $652K sold.

Based on aggregated 13F filings for Q3 2023.